98 related articles for article (PubMed ID: 31748877)
1. Local Inflammatory Response Can Predict Clinical Outcome in Patients with Curatively Resected Stage-IIB Colon Cancer: An Advanced Methodological Study.
Zengin M
Pathol Oncol Res; 2020 Jul; 26(3):1805-1816. PubMed ID: 31748877
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of tumour-infiltrating T lymphocytes in stage IIA (T3N0) colon cancer: A broad methodological study in a fairly homogeneous population.
Zengin M
Ann Diagn Pathol; 2019 Aug; 41():69-78. PubMed ID: 31146180
[TBL] [Abstract][Full Text] [Related]
3. Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients.
Zengin M
Pathol Res Pract; 2019 Nov; 215(11):152635. PubMed ID: 31564570
[TBL] [Abstract][Full Text] [Related]
4. Tumour budding in preoperative biopsy specimens is a useful prognostic index for identifying high-risk patients in early-stage (pN0) colon cancer.
Zengin M; Çifci A
Turk J Med Sci; 2020 Apr; 50(2):375-385. PubMed ID: 32011836
[TBL] [Abstract][Full Text] [Related]
5. The Proportion of Tumour-Stroma in Metastatic Lymph Nodes is An Accurately Prognostic Indicator of Poor Survival for Advanced-Stage Colon Cancers.
Zengin M; Benek S
Pathol Oncol Res; 2020 Oct; 26(4):2755-2764. PubMed ID: 32696416
[TBL] [Abstract][Full Text] [Related]
6. The role of cancer-related inflammation for prediction of poor survival in postmenopausal female patients with stage II/III colon cancer.
Zengin M; Karahan İ
Int Immunopharmacol; 2020 Aug; 85():106624. PubMed ID: 32492626
[TBL] [Abstract][Full Text] [Related]
7. Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis.
Harrison JC; Dean PJ; el-Zeky F; Vander Zwaag R
Hum Pathol; 1995 Jan; 26(1):31-8. PubMed ID: 7821914
[TBL] [Abstract][Full Text] [Related]
8. Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.
Konishi T; Shimada Y; Lee LH; Cavalcanti MS; Hsu M; Smith JJ; Nash GM; Temple LK; Guillem JG; Paty PB; Garcia-Aguilar J; Vakiani E; Gonen M; Shia J; Weiser MR
Am J Surg Pathol; 2018 Jun; 42(6):705-714. PubMed ID: 29624511
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
10. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
Ejaz A; Casadaban L; Maker AV
J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
13. Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease.
Sträter J; Hinz U; Hasel C; Bhanot U; Mechtersheimer G; Lehnert T; Möller P
Gut; 2005 May; 54(5):661-5. PubMed ID: 15831912
[TBL] [Abstract][Full Text] [Related]
14. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
[TBL] [Abstract][Full Text] [Related]
15. Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
Di Narzo AF; Tejpar S; Rossi S; Yan P; Popovici V; Wirapati P; Budinska E; Xie T; Estrella H; Pavlicek A; Mao M; Martin E; Scott W; Bosman FT; Roth A; Delorenzi M
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25246611
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.
Aydin D; Sendur MA; Kefeli U; Unal OU; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Ustaalioglu BB; Uysal M; Esbag O; Yazilitas D; Tanrıverdi O; Bilici A; Arpaci E; Berk V; Yetisyigit T; Ozdemir NY; Oztop I; Alacacioglu A; Aydin O; Ozcelik M; Yildirim E; Dinc N; Gumus M
Clin Colorectal Cancer; 2017 Sep; 16(3):220-227. PubMed ID: 27670893
[TBL] [Abstract][Full Text] [Related]
17. Preoperative platelet-lymphocyte ratio is an independent factor of poor prognosis after curative surgery for colon cancer.
Bailon-Cuadrado M; Choolani-Bhojwani E; Tejero-Pintor FJ; Sanchez-Gonzalez J; Rodriguez-Lopez M; Perez-Saborido B; Marcos-Rodriguez JL
Updates Surg; 2018 Mar; 70(1):33-39. PubMed ID: 29222632
[TBL] [Abstract][Full Text] [Related]
18. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
[TBL] [Abstract][Full Text] [Related]
19. The Number of Natural Killer Cells in the Largest Diameter Lymph Nodes Is Associated with the Number of Retrieved Lymph Nodes and Lymph Node Size, and Is an Independent Prognostic Factor in Patients with Stage II Colon Cancer.
Okada K; Sadahiro S; Chan LF; Ogimi T; Miyakita H; Saito G; Tanaka A; Suzuki T
Oncology; 2018; 95(5):288-296. PubMed ID: 30138925
[TBL] [Abstract][Full Text] [Related]
20. The impact of spontaneous tumour perforation on outcome following colon cancer surgery.
Abdelrazeq AS; Scott N; Thorn C; Verbeke CS; Ambrose NS; Botterill ID; Jayne DG
Colorectal Dis; 2008 Oct; 10(8):775-80. PubMed ID: 18266887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
